The NIH-funded Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium is developing and evaluating methods to improve the use of polygenic risk scores (PRS) to predict disease and health outcomes in diverse ancestry populations. 

For Researchers

Learn more about PRIMED Consortium research and ways to get involved.

For Consortium Members

Visit your customized dashboard to view consortium information.

ASHG Annual Meeting 2024 logo
PRIMED at ASHG 2024

We hope those attending the ASHG 2024 Annual Meeting in Denver, Colorado from November 5-9 check out the many PRIMED Consortium contributions! The Coordinating Center has put together a list of PRIMED posters, presentations, and other related events at ASHG 2024, which is also available on the PRIMED Consortium website's Abstracts page. Please also share with your colleagues and networks.


Read more
Colorful image of multiple open journals. Image by kconcha from Pixabay.
Recent publications
Alicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, Jiang Li, et al. Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes Nature Genetics.
Shen, Jiayi, et al. Hierarchical joint analysis of marginal summary statistics—Part I: Multipopulation fine mapping and credible set construction Genetic Epidemiology.

See more